The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Open accessAbstract
Therapeutic success in the superoxide dismutase (SOD1) mouse model of amyotrophic lateral sclerosis (ALS) has not translated into effective therapy for human ALS, calling into question the utility of such preclinical data for identifying therapeutic agents that are worthy of further study in humans. This random effects meta-analysis of treatment trials in the superoxide dismutase (SOD1) mouse was undertaken in order to explore possible reasons for this failure of translational research and to identify potential pharmacological interventions that might be used in either a preventative or therapeutic trial in familial ALS. Among studies in which treatment was initiated presymptomatically, the weighted mean differences (WMDs) comparing the active treatment to control treated animals were 12 days (onset), 13 days (survival) and 5 days (survival interval). Among studies in which treatment was initiated at the time of symptom onset, the WMDs were 15 days (survival) and 8 days (survival interval). Subgroup analysis suggests that drugs such as minocycline and Cox-2 inhibitors with an anti-inflammatory mechanism of action, and anti-oxidative agents such as creatine or the manganese porphyrin AEOL-10150, appear to be the most promising for preventative and therapeutic trials respectively in patients with familial ALS. These conclusions should be tempered by the methodological limitations of the relevant literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R., Mitchell, J., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 909
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Carboxyfullerenes as neuroprotective agents
Dugan, L. L., Turetsky, D. M., Du, C., Lobner, D., Wheeler, M., Almli, C. R., Shen, C. K.-F., Luh, T.-Y., Choi, D. W., & Lin, T.-S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9434 · Cited by 748
Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model
Li, M., Ona, V. O., Guégan, C., Chen, M., Jackson-Lewis, V., Andrews, L. J., Olszewski, A. J., Stieg, P. E., Lee, J.-P., Przedborski, S., et al. (2000) · Science · doi:10.1126/science.288.5464.335 · Cited by 716
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) · Annals of Neurology · doi:10.1002/ana.410390203 · Cited by 645
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., Carmeliet, P., & Mazarakis, N. D. (2004) · Nature · doi:10.1038/nature02544 · Cited by 590
Dupuis, L., Oudart, H., René, F., de Aguilar, J.-L. G., & Loeffler, J.-P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402026101 · Cited by 529
Kieran, D., Kalmar, B., Dick, J. R. T., Riddoch-Contreras, J., Burnstock, G., & Greensmith, L. (2004) · Nature Medicine · doi:10.1038/nm1021 · Cited by 522
Ralph, G. S., Radcliffe, P. A., Day, D. M., Carthy, J. M., Leroux, M. A., Lee, D. C. P., Wong, L.-F., Bilsland, L. G., Greensmith, L., Kingsman, S. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1205 · Cited by 506
Bcl-2: Prolonging Life in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis
Kostic, V., Jackson-Lewis, V., de Bilbao, F., Dubois-Dauphin, M., & Przedborski, S. (1997) · Science · doi:10.1126/science.277.5325.559 · Cited by 482
Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis
Kriz, J., Nguyen, M. D., & Julien, J.-P. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0487 · Cited by 411
Ryu, H., Smith, K., Camelo, S. I., Carreras, I., Lee, J., Iglesias, A. H., Dangond, F., Cormier, K. A., Cudkowicz, M. E., H. Brown, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03077.x · Cited by 353
Inhibition of ICE slows ALS in mice
Friedlander, R. M., Brown, R. H., Gagliardini, V., Wang, J., & Yuan, J. (1997) · Nature · doi:10.1038/40299 · Cited by 332
Drachman, D. B., Frank, K., Dykes‐Hoberg, M., Teismann, P., Almer, G., Przedborski, S., & Rothstein, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10374 · Cited by 307
Trial of celecoxib in amyotrophic lateral sclerosis
Cudkowicz, M. E., Shefner, J. M., Schoenfeld, D. A., Zhang, H., Andreasson, K. I., Rothstein, J. D., Drachman, D. B., & Northeast ALS Consortium (2006) · Annals of Neurology · doi:10.1002/ana.20903 · Cited by 301
Minocycline delays disease onset and mortality in a transgenic model of ALS
Van Den Bosch, L., Tilkin, P., Lemmens, G., & Robberecht, W. (2002) · Neuroreport · doi:10.1097/00001756-200206120-00018 · Cited by 296
A clinical trial of creatine in ALS
Shefner, J. M., Cudkowicz, M. E., Schoenfeld, D., Conrad, T., Taft, J., Chilton, M., Urbinelli, L., Qureshi, M., Zhang, H., Pestronk, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142992.81995.f0 · Cited by 293
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhao, Z., Lange, D. J., Voustianiouk, A., MacGrogan, D., Ho, L., Suh, J., Humala, N., Thiyagarajan, M., Wang, J., & Pasinetti, G. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-29 · Cited by 286
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
Jan Groeneveld, G., Veldink, J. H., van der Tweel, I., Kalmijn, S., Beijer, C., de Visser, M., Wokke, J. H. J., Franssen, H., & Berg, L. H. V. D. (2003) · Annals of Neurology · doi:10.1002/ana.10554 · Cited by 283
Wang, L.-J., Lu, Y.-Y., Muramatsu, S.-I., Ikeguchi, K., Fujimoto, K.-I., Okada, T., Mizukami, H., Matsushita, T., Hanazono, Y., Kume, A., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06920.2002 · Cited by 262
Emergency medicine animal research: does use of randomization and blinding affect the results?
Bebarta, V., Luyten, D., & Heard, K. (2003) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2003.tb00056.x · Cited by 244
Schütz, B., Reimann, J., Dumitrescu-Ozimek, L., Kappes-Horn, K., Landreth, G. E., Schürmann, B., Zimmer, A., & Heneka, M. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2038-05.2005 · Cited by 225
Benefit of valproic acid in suppressing disease progression of ALS model mice
Sugai, F., Yamamoto, Y., Miyaguchi, K., Zhou, Z., Sumi, H., Hamasaki, T., Goto, M., & Sakoda, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03765.x · Cited by 214
Klivenyi, P., Kiaei, M., Gardian, G., Calingasan, N. Y., & Beal, M. F. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02160.x · Cited by 200
Angelov, D. N., Waibel, S., Guntinas-Lichius, O., Lenzen, M., Neiss, W. F., Tomov, T. L., Yoles, E., Kipnis, J., Schori, H., Reuter, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530191100 · Cited by 193
The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies
Gurney, M. E. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00247-5 · Cited by 188
Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS
Zhang, W., Narayanan, M., & Friedlander, R. M. (2003) · Annals of Neurology · doi:10.1002/ana.10476 · Cited by 184
Kiaei, M., Petri, S., Kipiani, K., Gardian, G., Choi, D.-K., Chen, J., Calingasan, N. Y., Schafer, P., Muller, G. W., Stewart, C., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5253-05.2006 · Cited by 182
Acsadi, G., Anguelov, R. A., Yang, H., Toth, G., Thomas, R., Jani, A., Wang, Y., Ianakova, E., Mohammad, S., Lewis, R. A., et al. (2002) · Human Gene Therapy · doi:10.1089/104303402753812458 · Cited by 181
Hottinger, A. F., Fine, E. G., Gurney, M. E., Zurn, A. D., & Aebischer, P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01511.x · Cited by 180
Jung, C., Rong, Y., Doctrow, S., Baudry, M., Malfroy, B., & Xu, Z. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01784-0 · Cited by 177
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice
Koh, S.-H., Lee, S. M., Kim, H. Y., Lee, K.-Y., Lee, Y. J., Kim, H.-T., Kim, J., Kim, M.-H., Hwang, M. S., Song, C., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.056 · Cited by 161
Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 161
Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS
Zheng, C., Nennesmo, I., Fadeel, B., & Henter, J. (2004) · Annals of Neurology · doi:10.1002/ana.20223 · Cited by 157
Synergy of insulin‐like growth factor‐1 and exercise in amyotrophic lateral sclerosis
Kaspar, B. K., Frost, L. M., Christian, L. J., Umapathi, P., & Gage, F. H. (2005) · Annals of Neurology · doi:10.1002/ana.20451 · Cited by 154
Mohajeri, M. H., Figlewicz, D. A., & Bohn, M. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950017536 · Cited by 148
Pompl, P. N., Ho, L., Bianchi, M., McManus, T. E., Qin, W., & Pasinetti, G. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0876fje · Cited by 144
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice
Crow, J. P., Calingasan, N. Y., Chen, J., Hill, J. L., & Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20552 · Cited by 136
Andreassen, O. A., Dedeoglu, A., Klivènyi, P., Beal, M. F., & Bush, A. I. (2000) · Neuroreport · doi:10.1097/00001756-200008030-00029 · Cited by 135
Efficient three‐drug cocktail for disease induced by mutant superoxide dismutase
Križ, J., Gowing, G., & Julien, J. (2003) · Annals of Neurology · doi:10.1002/ana.10500 · Cited by 135
Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model
Waibel, S., Reuter, A., Malessa, S., Blaugrund, E., & Ludolph, A. C. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0481-5 · Cited by 134
Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid
Raman, C., McAllister, S. D., Rizvi, G., Patel, S., Moore, D. H., & Abood, M. E. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310016813 · Cited by 134
West, M. S., Mhatre, M., Ceballos, A., Floyd, R. A., Grammas, P., Gabbita, S. P., Hamdheydari, L., Mai, T., Mou, S., Pye, Q. N., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02700.x · Cited by 123
Virus‐delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis
Miller, T. M., Kaspar, B. K., Kops, G. J. P. L., Yamanaka, K., Christian, L. J., Gage, F. H., & Cleveland, D. W. (2005) · Annals of Neurology · doi:10.1002/ana.20453 · Cited by 123
Tortarolo, M., Grignaschi, G., Calvaresi, N., Zennaro, E., Spaltro, G., Čolović, M., Fracasso, C., Guiso, G., Elger, B., Schneider, H. H., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20715 · Cited by 116
Intrathecal cyclosporin prolongs survival of late-stage ALS mice
Keep, M. F., Elmér, E., Fong, K. S. K., & Csiszár, K. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02012-1 · Cited by 114
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis
Holzbaur, E. L. F., Howland, D., Weber, N., Wallace, K. E., She, Y., Kwak, S., Tchistiakova, L. A., Murphy, E. K., Hinson, J., Karim, R., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.05.009 · Cited by 104
Turner, B. J., Cheah, I. K.-M., Macfarlane, K. J., Lopes, E. C., Petratos, S., Langford, S. J., & Cheema, S. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02053.x · Cited by 100
Andreassen, O. A., Dedeoglu, A., Friedlich, A., Ferrante, K. L., Hughes, D., Szabo, C., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7633 · Cited by 96
Mignini, L. E., & Khan, K. S. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-10 · Cited by 94
Bordet, T. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.18.1925 · Cited by 92
Wu, A. S., Kiaei, M., Aguirre, N., Crow, J. P., Calingasan, N. Y., Browne, S. E., & Beal, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01639.x · Cited by 88
Nagano, S., Fujii, Y., Yamamoto, T., Taniyama, M., Fukada, K., Yanagihara, T., & Sakoda, S. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00014-6 · Cited by 83
Nagano, S., Ogawa, Y., Yanagihara, T., & Sakoda, S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00227-x · Cited by 81
Ferrante, R. J., Klein, A., Dedeoglu, A., & Beal, M. F. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:1:89 · Cited by 78
Hamadeh, M. J., Rodriguez, M. C., Kaczor, J. J., & Tarnopolsky, M. A. (2004) · Muscle & Nerve · doi:10.1002/mus.20255 · Cited by 76
Kira, Y., Nishikawa, M., Ochi, A., Sato, E. F., & Inoue, M. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.052 · Cited by 69
Manabe, Y., NAGANO, I., Gazi, M. S. A., Murakami, T., Shiote, M., Shoji, M., Kitagawa, H., Setoguchi, Y., & Abe, K. (2002) · APOPTOSIS · doi:10.1023/a:1016123413038 · Cited by 68
Canton, T., Böhme, G. A., Boireau, A., Bordier, F., Mignani, S. M., Jimonet, P., Jahn, G., Alavijeh, M. S., Stygall, J., Roberts, S., et al. (2001) · PubMed · Cited by 68
Kirkinezos, I. G., Hernandez, D., Bradley, W. G., & Moraes, C. T. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02181.x · Cited by 66
Protection by dietary zinc in ALS mutant G93A SOD transgenic mice
Ermilova, I. P., Ermilov, V. B., Levy, M., Ho, E., Pereira, C. B., & Beckman, J. S. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.045 · Cited by 66
Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice
Jiang, F., DeSilva, S., & Turnbull, J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00421-4 · Cited by 65
Reinholz, M. M., Merkle, C. M., & Poduslo, J. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7142 · Cited by 62
Turner, B. J., Murray, S. S., Piccenna, L. G., Lopes, E. C., Kilpatrick, T. J., & Cheema, S. S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20256 · Cited by 61
Karlsson, J., Fong, K. S. K., Hansson, M. J., Elmàr, E., Csiszár, K., & Keep, M. F. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.101.1.0128 · Cited by 60
Snow, R. J., Turnbull, J., da Silva, S., Jiang, F., & Tarnopolsky, M. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00212-4 · Cited by 54
Maragakis, N. J., Jackson, M. T., Ganel, R., & Rothstein, J. D. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01386-1 · Cited by 49
Trieu, V. N., Liu, R., Liu, X., & Uckun, F. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1905 · Cited by 44
Poduslo, J. F., Whelan, S. L., Curran, G. L., & Wengenack, T. M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200012)48:6<943::aid-ana18>3.0.co;2-1 · Cited by 40
Colivelin prolongs survival of an ALS model mouse
Chiba, T., Yamada, M., Sasabe, J., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.184 · Cited by 40
Azari, M. F., Galle, A., Lopes, E. C., Kurek, J. B., & Cheema, S. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03156-0 · Cited by 36
Turner, B. J., Rembach, A., Spark, R., Lopes, E. C., & Cheema, S. S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10796 · Cited by 35
Narai, H., Nagano, I., Ilieva, H., Shiote, M., Nagata, T., Hayashi, T., Shoji, M., & Abe, K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20668 · Cited by 33
Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity
Cudkowicz, M., Pastusza, K. A., Sapp, P. C., Mathews, R., Leahy, J. M., Pasinelli, P., Francis, J. W., Jiang, D., Andersen, J. K., & Brown, R. H. (2002) · Neurology · doi:10.1212/wnl.59.5.729 · Cited by 31
Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS
Azari, M. F., Profyris, C., Grande, M. R. L., Lopes, E. C., Hirst, J. J., Petratos, S., & Cheema, S. S. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00987.x · Cited by 29
The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis
Feeney, S. J., Austin, L., Bennett, T. M., Kurek, J. B., Jean-François, M. J. B., Muldoon, C., & Byrne, E. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00217-5 · Cited by 29
Cited by
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Can Animal Models of Disease Reliably Inform Human Studies?
van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., & Macleod, M. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000245 · Cited by 1,354
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Barber, S. C., & Shaw, P. J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.018 · Cited by 617
Metadata
- Authors
- Benatar, M.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 26
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2076461577
- Cited by
- 350
- References
- 81
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.